Aldeyra Therapeutics (ALDX) Debt Ratio (2013 - 2026)
Aldeyra Therapeutics' (ALDX) quarterly Debt Ratio came in at 0.23 in Q1 2026, up 42.05% YoY from 0.16 in Q1 2025, and down 45.18% on a QoQ basis from 0.42 in Q4 2025.
Aldeyra Therapeutics (ALDX) Debt Ratio (2013 - 2026) Analysis & Trends
Aldeyra Therapeutics (ALDX) has 14 years of Debt Ratio data on file, last reported at 0.23 in Q1 2026.
- Quarterly Debt Ratio rose 42.05% year-over-year to 0.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.23 (up 42.05% YoY) and the FY2025 annual result came in at 0.42, up 192.14% from the prior year.
- Debt Ratio slipped to 0.23 in Q1 2026, from 0.42 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.42 in Q4 2025 to a low of 0.07 in Q1 2022.
- A 5-year average of 0.16 and a median of 0.12 in 2024 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio plunged 50.62% — and 2025, when it soared 198.03%.
- Tracing ALDX's Debt Ratio over 5 years: stood at 0.09 in 2022, then climbed by 16.91% to 0.1 in 2023, then jumped by 40.72% to 0.14 in 2024, then surged by 192.14% to 0.42 in 2025, then slumped by 45.18% to 0.23 in 2026.
- The last three Debt Ratio figures came in at 0.23 (Q1 2026), 0.42 (Q4 2025), and 0.39 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | Aldeyra Therapeutics | 91.08 Mn | 91.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | 0.42 |
| Sep 30, 2025 | 0.39 |
| Jun 30, 2025 | 0.18 |
| Mar 31, 2025 | 0.16 |
| Dec 31, 2024 | 0.14 |
| Sep 30, 2024 | 0.13 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 0.10 |
| Sep 30, 2023 | 0.11 |
| Jun 30, 2023 | 0.10 |
| Mar 31, 2023 | 0.09 |
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.14 |
| Jun 30, 2022 | 0.10 |
| Mar 31, 2022 | 0.07 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.06 |